Drug
Apixaban 5 MG Oral Tablet
Apixaban 5 MG Oral Tablet is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_1
1
33%
Ph phase_4
1
33%
Ph phase_3
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Active, not recruiting1
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 11 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)
Trials by Status
active_not_recruiting133%
not_yet_recruiting133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
not_yet_recruitingphase_3
DIrect Oral Anticoagulation and Bioprothesis Aortic Valve
NCT05687448
recruitingphase_4
BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.
NCT04666454
active_not_recruitingphase_1
Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant
NCT06372483
Clinical Trials (3)
Showing 3 of 3 trials
NCT05687448Phase 3
DIrect Oral Anticoagulation and Bioprothesis Aortic Valve
NCT04666454Phase 4
BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.
NCT06372483Phase 1
Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3